Replication Capacity of Viruses from Acute Infection Drives HIV-1 Disease Progression

被引:17
|
作者
Selhorst, Philippe [1 ]
Combrinck, Carina [1 ]
Ndabambi, Nonkululeko [1 ]
Ismail, Sherazaan D. [1 ]
Abrahams, Melissa-Rose [1 ]
Lacerda, Miguel [2 ]
Samsunder, Natasha [3 ]
Garrett, Nigel [3 ]
Karim, Quarraisha Abdool [3 ,4 ]
Karim, Salim S. Abdool [3 ,4 ]
Williamson, Carolyn [1 ,3 ,5 ]
机构
[1] Univ Cape Town, Inst Infect Dis & Mol Med, Fac Hlth Sci, Dept Pathol, Cape Town, South Africa
[2] Univ Cape Town, Fac Sci, Dept Stat Sci, Cape Town, South Africa
[3] Univ KwaZulu Natal, Ctr AIDS Programme Res South Africa, Durban, South Africa
[4] Columbia Univ, Dept Epidemiol, New York, NY USA
[5] Natl Hlth Lab Serv, Johannesburg, South Africa
关键词
HIV; replication capacity; acute infection; disease progression; tenofovir; CAPRISA; 004; infectivity; isolates; heterosexual transmission; pathogenesis; VIRAL-LOAD; TYPE-1; REPLICATION; TENOFOVIR GEL; MAJOR DETERMINANT; SEX-DIFFERENCES; GAG-PROTEASE; TRANSMISSION; IMPACT; FITNESS; NEF;
D O I
10.1128/JVI.01806-16
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
The viral genotype has been shown to play an important role in HIV pathogenesis following transmission. However, the viral phenotypic properties that contribute to disease progression remain unclear. Most studies have been limited to the evaluation of Gag function in the context of a recombinant virus backbone. Using this approach, important biological information may be lost, making the evaluation of viruses obtained during acute infection, representing the transmitted virus, a more biologically relevant model. Here, we evaluate the roles of viral infectivity and the replication capacity of viruses from acute infection in disease progression in women who seroconverted in the CAPRISA 004 tenofovir microbicide trial. We show that viral replication capacity, but not viral infectivity, correlates with the set point viral load (Spearman r = 0.346; P = 0.045) and that replication capacity (hazard ratio [HR] = 4.52; P = 0.01) can predict CD4 decline independently of the viral load (HR = 2.9; P = 0.004) or protective HLA alleles (HR = 0.61; P = 0.36). We further demonstrate that Gag-Pro is not the main driver of this association, suggesting that additional properties of the transmitted virus play a role in disease progression. Finally, we find that although viruses from the tenofovir arm were 2-fold less infectious, they replicated at rates similar to those of viruses from the placebo arm. This indicates that the use of tenofovir gel did not select for viral variants with higher replication capacity. Overall, this study supports a strong influence of the replication capacity in acute infection on disease progression, potentially driven by interaction of multiple genes rather than a dominant role of the major structural gene gag. IMPORTANCE HIV disease progression is known to differ between individuals, and defining which fraction of this variation can be attributed to the virus is important both clinically and epidemiologically. In this study, we show that the replication capacity of viruses isolated during acute infection predicts subsequent disease progression and drives CD4 decline independently of the viral load. This provides further support for the hypothesis that the replication capacity of the transmitted virus determines the initial damage to the immune system, setting the pace for later disease progression. However, we did not find evidence that the major structural gene gag drives this correlation, highlighting the importance of other genes in determining disease progression.
引用
收藏
页数:15
相关论文
共 50 条
  • [21] Recombination-mediated escape from primary CD8+T cells in acute HIV-1 infection
    Ritchie, Adam John
    Cai, Fangping
    Smith, Nicola M. G.
    Chen, Sheri
    Song, Hongshuo
    Brackenridge, Simon
    Karim, Salim S. Abdool
    Korber, Bette T.
    McMichael, Andrew J.
    Gao, Feng
    Goonetilleke, Nilu
    RETROVIROLOGY, 2014, 11 : 1 - 10
  • [22] HIV-1 coreceptor usage, transmission, and disease progression
    Philpott, SM
    CURRENT HIV RESEARCH, 2003, 1 (02) : 217 - 227
  • [23] Association of polymorphisms in the LEDGF/p75 gene (PSIP1) with susceptibility to HIV-1 infection and disease progression
    Madlala, Paradise
    Gijsbers, Rik
    Christ, Frauke
    Hombrouck, Anneleen
    Werner, Lise
    Mlisana, Koleka
    An, Ping
    Karim, Salim S. Abdool
    Winkler, Cheryl A.
    Debyser, Zeger
    Ndung'u, Thumbi
    AIDS, 2011, 25 (14) : 1711 - 1719
  • [24] In vivo HIV-1 replicative capacity in early and advanced infection
    Phillips, AN
    McLean, AR
    Loveday, C
    Tyrer, M
    Bofill, M
    Devereux, H
    Madge, S
    Dykoff, A
    Drinkwater, A
    Burke, A
    Huckett, L
    Janossy, G
    Johnson, MA
    AIDS, 1999, 13 (01) : 67 - 73
  • [25] Virulence and Pathogenesis of HIV-1 Infection: An Evolutionary Perspective
    Fraser, Christophe
    Lythgoe, Katrina
    Leventhal, Gabriel E.
    Shirreff, George
    Hollingsworth, T. Deirdre
    Alizon, Samuel
    Bonhoeffer, Sebastian
    SCIENCE, 2014, 343 (6177) : 1328 - +
  • [26] Viral phenotype in mother-to-child HIV-1 transmission and disease progression of vertically acquired HIV-1 infection
    DeRossi, A
    Ometto, L
    Masiero, S
    Zanchetta, M
    ChiecoBianchi, L
    ACTA PAEDIATRICA, 1997, 86 : 22 - 28
  • [27] Balance between transmitted HLA preadapted and nonassociated polymorphisms is a major determinant of HIV-1 disease progression
    Monaco, Daniela C.
    Dilernia, Dario A.
    Fiore-Gartland, Andrew
    Yu, Tianwei
    Prince, Jessica L.
    Dennis, Kristine K.
    Qin, Kai
    Schaefer, Malinda
    Claiborne, Daniel T.
    Kilembe, William
    Tang, Jianming
    Price, Matt A.
    Farmer, Paul
    Gilmour, Jill
    Bansal, Anju
    Allen, Susan
    Goepfert, Paul
    Hunter, Eric
    JOURNAL OF EXPERIMENTAL MEDICINE, 2016, 213 (10) : 2049 - 2063
  • [28] Virus-Host Gene Interactions Define HIV-1 Disease Progression
    Monaco, Daniela C.
    Ende, Zachary
    Hunter, Eric
    VIRUSES, GENES, AND CANCER, 2017, 407 : 31 - 63
  • [29] Thymic Function Is Most Severely Impaired in Chronic HIV-1 Infection, but Individuals With Faster Disease Progression During Early HIV-1 Infection Expressed Lower Levels of RTEs
    He, Sijia
    Zhang, Zining
    Fu, Yajing
    Qin, Chaolong
    Li, Sha
    Han, Xiaoxu
    Xu, Junjie
    Liu, Jing
    Jiang, Yongjun
    Shang, Hong
    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2015, 70 (05) : 472 - 478
  • [30] HERPES-ZOSTER, IMMUNOLOGICAL DETERIORATION AND DISEASE PROGRESSION IN HIV-1 INFECTION
    VEENSTRA, J
    KROL, A
    VANPRAAG, RME
    FRISSEN, PHJ
    SCHELLEKENS, PTA
    LANGE, JMA
    COUTINHO, RA
    VANDERMEER, JTM
    AIDS, 1995, 9 (10) : 1153 - 1158